What Is AbCellera Biologics Inc. (ABCL) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, AbCellera Biologics Inc.'s intrinsic value is estimated at $2.09. Trading at its current price of $6.52, the valuation engine raises significant caution: 9 of 10 models flag downside risk, projecting an average implied return of -68.0%. Notably, PWERM sees the most upside at -3.0% (fair value: $6.33), while Sentiment SOTP is the most conservative at -96.2% ($0.25). The spread between these extremes — +93.3% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About ABCL?
10 of 13 models are currently active for ABCL. All 10 active models suggest the stock trades above fair value. The Bayesian DCF estimates ABCL's intrinsic value at $3.49, implying -46.5% downside from the current price. See which stocks rank higher →
How Does ABCL Rank in Biotechnology?
Among 62 Biotechnology stocks, ABCL ranks #5 by Quality of Company score. CirclFi's QOC score of 7.1/10 evaluates 32 fundamental signals. A score of 7.1 indicates above-average quality.
See all Most Undervalued Biotechnology Stocks →
The Biotechnology sector introduces analytical considerations specific to life sciences company businesses. For AbCellera Biologics Inc., metrics like market exclusivity window provide important context that general-purpose valuation models may underweight.
Is ABCL a Value Trap?
CirclFi's Value Trap algorithm assigns ABCL a score of 15/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for AbCellera Biologics Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, AbCellera Biologics Inc. scores 7.1 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +93.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ABCL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ABCL's 10 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad